Abstract
Cancer can be considered a disease of the cell cycle. In fact, virtually all cancers have alterations in genes involved in controlling the progression of some phase of the cell cycle. This progression is subject to a negative control that is exercised mainly by inhibitors of cyclin-dependent kinases (CKIs).Initially described as a potent CKI and therefore a negative regulator of cell cycl…